Synthego · 17 hours ago
Chemistry Development Intern - Process Development
Synthego is a pioneering force in the biotechnology industry, dedicated to advancing the frontiers of CRISPR cell and gene therapies through cutting-edge CRISPR technology and expertise. This summer, they are looking to welcome a Chemistry Development intern to partner with their team on Oligonucleotide Synthesis, providing an opportunity to gain on-the-job experience in biotech.
Artificial Intelligence (AI)BiotechnologyGeneticsIndustrial AutomationInnovation ManagementLife ScienceMachine LearningSoftware
Responsibilities
Learn about Synthego's RNA synthesis process
Develop practical skills in process optimization
Use experimental design principles
Optimize parameters for oligonucleotide synthesis
Perform Data Analysis and present findings
Shadowing, mentoring, and training opportunities with industry professionals
Opportunity to participate in networking events and company meetings
Qualification
Required
Pursuing a degree in Biology, Chemistry, Bioengineering, Chemical Engineering, or other similar degrees
Interest in learning about synthetic RNA/DNA
Interest in learning about process development
Strong written and verbal communication skills
Able to multi-task and prioritize work effectively
Ability to work for 10 weeks within a period in June to August
Preferred
Experience working in labs
Experience with Python or C
Benefits
School credit if applicable
Letter of reference
Competitive pay
Free catered lunches on Tuesdays and Thursdays
Company
Synthego
Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.
H1B Sponsorship
Synthego has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (4)
2023 (3)
2022 (19)
2021 (13)
2020 (2)
Funding
Current Stage
Late StageTotal Funding
$459.69MKey Investors
Perceptive AdvisorsFounders Fund8VC
2025-06-26Acquired
2022-02-17Series E· $200M
2020-08-26Series D· $100M
Recent News
2025-07-22
Company data provided by crunchbase